The European Medicines Regulator said it has begun reviewing AstraZeneca’s application for an antibody-based therapy for COVID-19, a key step towards approval of the treatment in the region, but did not provide a timeline for review.
EU moves towards limiting carbon emissions from shipping
March 24, 2023
